2023: 2Morrow® Inc., was awarded USD 1.9 Million NIH Grant to Develop a Digital Therapeutic for Patients with Chronic Pain.
According to MarkNtel Advisors study, The Global Digital Therapeutics Market is estimated to grow at a CAGR of around 20% during the forecast period, i.e., 2024-30.
The integration of virtual reality (VR) technology holds promising prospects within the Global Digital Therapeutics Market. It offers immersive solutions for the treatment & management of various conditions, such as strokes, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), anxiety disorders, substance abuse, etc. With the prevalence of these diseases on the rise, integrating VR into therapeutic interventions presents an opportunity to enhance patient engagement & adherence to treatment plans. Also, by immersing users in simulated environments, VR facilitates behavior change, pain management, and cognitive therapy, thereby expanding the scope of digital therapeutics into new therapeutic areas and improving overall healthcare outcomes. Hence, the Global Digital Therapeutics Market would experience profitable opportunities in the coming years.
✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Download Free Sample Copy @ https://www.marknteladvisors.com/query/request-sample/digital-therapeutics-market.html
Key Findings in Digital Therapeutics Market:
| Historical Years | 2019-2022 |
| Base Years | 2023 |
| Forecast Years | 2024-2030 |
| Key Report Highlights | · Market Dimensions & Projections· Pricing Evaluation,· Recent Strategic Moves by Companies,· Primary Stakeholders,· Analysis of Import and Export Trends,· Competitive Landscape Assessment,· Emerging Opportunities,· Market Trends and Indicators |
| Reports Delivery Format | Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address. |
Digital Therapeutics Market Key Players:
Omada Health Inc., Google (Fitbit Health Solutions), 2Morrow® Inc., Teladoc Health. Inc. (Livongo), ResMed (Propeller Health), Aptar (Voluntis, Inc.), Welldoc, Inc., Canary Health, Noom, Inc., Biofourmis, Click Therapeutics, Better Therapeutics, Cognoa, CogniFit Inc., Virta Health, Others,
Market Segmentation Overview:
By Product
-Software
-Hardware
The Software category held a major share of the Global Digital Therapeutics Market. The growth owes to the increased prevalence of chronic & infectious diseases necessitating the adoption of scalable & cost-effective solutions, such as digital therapeutics. Also, the aging population at risk for several chronic diseases demands effective solutions, such as digital therapeutics for managing chronic conditions, promoting adherence to treatment plans, and enabling remote monitoring. Hence, this becomes more crucial for elderly individuals, who may have mobility restrictions or require frequent healthcare interventions, thereby driving the demand for digital therapeutic software.
By Application
-Preventive
–Pre-Diabetes
–Obesity
–Smoking Cessation
–Others (Hypertension, Sleep Hygiene, etc.)
-Treatment/Care
–Cardiovascular Diseases (CVDs)
–Central Nervous System Diseases
–Diabetes
–Musculoskeletal Diseases
–Others (Respiratory Diseases, Drug Substance Abuse, etc.)
By Business Model
-Business-to-Consumer (B2C)
-Business-to-Business (B2B)
Read Full Report @ https://www.marknteladvisors.com/research-library/digital-therapeutics-market.html
By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
The Digital Therapeutics Industry Recent Development:
2024: Otsuka Pharmaceutical, Co. Ltd. and Click Therapeutics, Inc., announced that the US Food and Drug Administration (FDA) has cleared Rejoyn™ (developed as CT-152), the first prescription digital therapeutic authorized for the treatment of major depressive disorder (MDD).
About MarkNtel Advisors:
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Being one of the most efficient market research companies in India, our specialized team of experienced & efficient market research professionals is capable of grasping every minute and valuable information & data of the market to offer our clients with satisfactory details. Our company has served the biggest market research firms in India at leading positions and is proficient in managing all types of market research projects.
Have an Any Query,
Call Us – US Office: +1 628 895 8081
Email – sales@marknteladvisors.com
Address Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
